Storman D, Swierz M, Mitus J, Pedziwiatr M, Liang N, Wolff R
Cochrane Database Syst Rev. 2024; 3:CD010163.
PMID: 38534000
PMC: 10966940.
DOI: 10.1002/14651858.CD010163.pub3.
Serenari M, Ratti F, Stocco A, De Cobelli F, Serra C, Santangelo D
Surg Endosc. 2024; 38(5):2611-2621.
PMID: 38499784
DOI: 10.1007/s00464-024-10757-3.
Zensen S, Bucker A, Meetschen M, Haubold J, Opitz M, Theysohn J
Eur Radiol. 2023; 34(5):3322-3330.
PMID: 37935847
PMC: 11126481.
DOI: 10.1007/s00330-023-10412-w.
Koza A, Bhogal R, Fotiadis N, Mavroeidis V
Biomedicines. 2023; 11(4).
PMID: 37189680
PMC: 10135821.
DOI: 10.3390/biomedicines11041062.
Zhang J, Fu Y, Wang J
Wideochir Inne Tech Maloinwazyjne. 2023; 17(4):549-560.
PMID: 36818506
PMC: 9909773.
DOI: 10.5114/wiitm.2022.119585.
Is microwave ablation therapy as effective as colorectal liver metastases in noncolorectal liver metastases?.
Danisan G, Kupeli A, Taydas O
Turk J Med Sci. 2022; 52(4):1336-1343.
PMID: 36326409
PMC: 10388064.
DOI: 10.55730/1300-0144.5440.
Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist.
Torres-Jimenez J, Esteban-Villarrubia J, Ferreiro-Monteagudo R, Carrato A
Cancers (Basel). 2021; 13(23).
PMID: 34885047
PMC: 8656541.
DOI: 10.3390/cancers13235938.
Image-guided locoregional non-intravascular interventional treatments for hepatocellular carcinoma: Current status.
Qian K, Zhang F, Allison S, Zheng C, Yang X
J Interv Med. 2021; 4(1):1-7.
PMID: 34805939
PMC: 8562266.
DOI: 10.1016/j.jimed.2020.10.008.
Image-Guided Ablation for Colorectal Liver Metastasis: Principles, Current Evidence, and the Path Forward.
Lin Y, Paolucci I, Brock K, Odisio B
Cancers (Basel). 2021; 13(16).
PMID: 34439081
PMC: 8394430.
DOI: 10.3390/cancers13163926.
Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria.
Zhou Y, Yang Y, Zhou B, Wang Z, Zhu R, Chen X
J Hepatocell Carcinoma. 2021; 8:625-644.
PMID: 34189133
PMC: 8232857.
DOI: 10.2147/JHC.S298709.
Value of spectral detector computed tomography for the early assessment of technique efficacy after microwave ablation of hepatocellular carcinoma.
Reimer R, Grosse Hokamp N, Niehoff J, Zopfs D, Lennartz S, Heidar M
PLoS One. 2021; 16(6):e0252678.
PMID: 34129650
PMC: 8205161.
DOI: 10.1371/journal.pone.0252678.
Differential Imaging of Liver Tumors before and after Microwave Ablation with Electrode Displacement Elastography.
Pohlman R, Hinshaw J, Ziemlewicz T, Lubner M, Wells S, Lee Jr F
Ultrasound Med Biol. 2021; 47(8):2138-2156.
PMID: 34011451
PMC: 8243838.
DOI: 10.1016/j.ultrasmedbio.2021.03.027.
Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma.
Gaia S, Ciruolo M, Ribaldone D, Rolle E, Migliore E, Mosso E
Curr Oncol. 2021; 28(2):1034-1044.
PMID: 33669107
PMC: 8025753.
DOI: 10.3390/curroncol28020101.
Interventional Oncology Approach to Hepatic Metastases.
OLeary C, Soulen M, Shamimi-Noori S
Semin Intervent Radiol. 2020; 37(5):484-491.
PMID: 33328704
PMC: 7732560.
DOI: 10.1055/s-0040-1719189.
Treatment Options for Early-Stage Hepatocellular Carcinoma.
Tabori N, Sivananthan G
Semin Intervent Radiol. 2020; 37(5):448-455.
PMID: 33328700
PMC: 7732557.
DOI: 10.1055/s-0040-1720950.
Colorectal liver metastases: Current management and future perspectives.
Martin J, Petrillo A, Smyth E, Shaida N, Khwaja S, Cheow H
World J Clin Oncol. 2020; 11(10):761-808.
PMID: 33200074
PMC: 7643190.
DOI: 10.5306/wjco.v11.i10.761.
Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: A PRISMA-compliant systematic review and meta-analysis.
Han J, Fan Y, Wang K
Medicine (Baltimore). 2020; 99(43):e22703.
PMID: 33120763
PMC: 7581069.
DOI: 10.1097/MD.0000000000022703.
Critical review of multidisciplinary non-surgical local interventional ablation techniques in primary or secondary liver malignancies.
Kovacs A, Iezzi R, Cellini F, Lancellotta V, Bischoff P, Carchesio F
J Contemp Brachytherapy. 2020; 11(6):589-600.
PMID: 31969919
PMC: 6964346.
DOI: 10.5114/jcb.2019.90466.
[Locoregional and local ablative treatment options for liver tumors].
Hinrichs J, Wacker F
Internist (Berl). 2020; 61(2):158-163.
PMID: 31919532
DOI: 10.1007/s00108-019-00725-8.
Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching.
Du S, Yang J, Chen J, Zhou W, Sun Y
PLoS One. 2020; 15(1):e0227242.
PMID: 31918433
PMC: 6952252.
DOI: 10.1371/journal.pone.0227242.